2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,577,400 | +41.5% | 657,500 | +265.3% | 1.46% | +44.6% |
| Q2 2023 | $1,821,600 | -41.0% | 180,000 | -40.5% | 1.01% | -52.5% |
| Q1 2023 | $3,085,500 | +82.9% | 302,500 | +68.1% | 2.13% | +27.8% |
| Q4 2022 | $1,686,600 | +73.0% | 180,000 | +168.7% | 1.67% | +66.4% |
| Q3 2022 | $975,000 | +280.9% | 67,000 | +570.0% | 1.00% | +1234.7% |
| Q4 2021 | $256,000 | – | 10,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |